AHCL17.78

Anlon Healthcare Limited

· Pharma & Health
₹ CrorePeersANUHPHRWANBURYBAJAJHCAREZIMLABTHEMISMEDLINCOLNSIGACHIVALIANTLABMcap ₹94.5 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
AHCL
FY26
ANUHPHR
FY26
WANBURY
FY25
BAJAJHCARE
FY26
Peer
Median
Valuation — at last close
P/E2.91×22.37×25.82×66.57×25.82× -89%
P/B0.37×2.61×13.30×2.09×2.61× -86%
EV/EBITDA2.82×14.03×12.55×12.52×12.55× -78%
Market Cap₹94.5 Cr₹919 Cr₹789 Cr₹1,116 Cr₹919 Cr -90%
Growth
Revenue CAGR 3Y5.46%-3.18%1.14%
Revenue CAGR 5Y10.29%10.29%
Net Income CAGR 3Y-27.91%-28.44%-28.18%
Revenue YoY (latest Q)3.93%24.47%11.28%11.28%
Net Income YoY (latest Q)37.63%1200.41%15.75%37.63%
Profitability
EBITDA Margin27.63%8.00%12.73%17.15%12.73% +117%
Net Income Margin16.92%5.32%5.09%2.58%5.09% +232%
Return on Common Equity11.19%11.65%51.51%2.96%11.65% -4%
Return on Capital Employed17.26%14.21%26.33%12.80%14.21% +21%
Return on Assets7.78%7.36%7.38%1.71%7.36% +6%
Credit & Quality
Total Debt/Equity0.17×0.00×2.92×0.44×0.44× -61%
Interest Coverage12.30×106.58×1.71×3.48×3.48× +253%
Scale — latest FY
Revenue / Total Income₹172 Cr₹772 Cr₹600 Cr₹611 Cr₹611 Cr -72%
Net Income₹29.1 Cr₹41 Cr₹30.5 Cr₹15.8 Cr₹30.5 Cr -5%
Total Assets₹374 Cr₹557 Cr₹414 Cr₹923 Cr₹557 Cr -33%
EPS₹6.11₹4.1₹9.32₹4.98₹4.98 +23%
Book Value per Share₹47.94₹35.14₹18.09₹158.34₹35.14 +36%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.